NIPT
Progenity to Close Genetics Lab as Focus Shifts to Therapeutics
The firm will no longer offer its Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, or Resura Prenatal Test.
Illumina, Roche Agree to Settle NIPT Patent Lawsuits
The settlement will end a patent battle that has raged since 2012, but the terms have not yet been disclosed.
Yourgene, Alliance Global Sign Distribution Deal for Middle East, Africa
Dubai-based Alliance Global will distribute Yourgene's noninvasive prenatal tests, reproductive health tests, and other products across a broad range of territories.
Echelon Diagnostics, Cradle Genomics Ink Noninvasive Prenatal Diagnostics Partnership
The companies are working together to accelerate the development of Cradle's fetal cell isolation and analysis technology for noninvasive prenatal testing.
The company is positioning the blood-based test as an alternative to invasive chorionic villus sampling, the current standard in Denmark.
Feb 25, 2021
Natera Revenues Grow 35 Percent in Q4
Nov 9, 2020
Progenity Q3 Revenues Increase 38 Percent
Oct 26, 2020
Yourgene H1 Revenues Up 5 Percent
Oct 23, 2020
BTIG Initiates Coverage of Progenity With Buy Rating
Sep 11, 2020